Phase II Study of QLC2519 in Pediatric Solid Tumor Participants

Clinical trial NCT07724756 · RECRUITING

Trial details

NCT number: NCT07724756
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pediatric Malignant Solid Tumor Febrile Neutropenia (FN)Neutropenia

Start date: 2026-06-26
Primary completion: 2027-06-26
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.